Skip to main content
. 2018 Nov 23;27(2):293–302. doi: 10.1016/j.jsps.2018.11.011

Table 1.

Physical characteristics of ACY loaded PLGA-NPs.

PLGA-NPs Particle size (nm) ± SD Polydispersity ± SD Zeta-potential (mV) ± SD % Encapsulation ± SD % Drug loading ± SD
With polyvinylpyrrolidone (PVP, w/v)
0.5%, (F1) 785.35 ± 35.91 0.484 ± 0.008 −14.51 ± 7.01 58.42 ± 3.58 5.92 ± 1.06
1.0%, (F2) 174.46 ± 15.25 0.297 ± 0.015 −15.82 ± 3.69 60.25 ± 4.92 6.75 ± 1.32
1.5%, (F3) 295.51 ± 17.38 0.222 ± 0.012 −6.04 ± 3.77 63.34 ± 3.85 7.26 ± 1.41



With D-α-tocopheryl polyethylene glycol 1000 succinate (TPGS, w/v)
0.1%, (F4) 293.61 ± 13.78 0.257 ± 0.013 15.28 ± 2.05 32.72 ± 2.98 7.67 ± 1.23
0.3%, (F5) 262.38 ± 11.85 0.255 ± 0.011 15.14 ± 2.81 74.12 ± 6.19 8.65 ± 1.09
0.6%, (F6) 716.15 ± 39.23 0.416 ± 0.023 11.67 ± 1.62 80.15 ± 7.85 5.15 ± 1.38

The values in bold indicate the selected formulation and its parameters.